Best General Drug Manufacturer Stocks to Buy Now (2025)Top general drug manufacturer stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best general drug manufacturer stocks to buy now. Learn More.
Industry: Drug Manufacturers - Gene...
A
General Drug Manufacturers is Zen Rated A and is the 5th ranked industry out of 145 stock market industries
Learn how the Zen Ratings work| Ticker | Company | Zen Rating | Growth | Market Cap | Revenue | EBITDA | Earnings | EPS | Rev. Y/Y | Rev. 5Y | Earn. Y/Y | Earn. 5Y | Earnings Date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| GSK | GSK PLC | $92.51B | $42.74B | $7.47B | $4.63B | $2.27 | 8.86% | -0.44% | -8.36% | -11.59% | 2025-10-29 | ||
| NVS | NOVARTIS AG | $254.84B | $55.19B | $27.72B | $13.65B | $6.91 | 12.95% | 2.19% | -12.09% | 16.64% | 2025-10-28 | ||
| BIIB | BIOGEN INC | $22.00B | $10.00B | $2.61B | $1.53B | $10.48 | 3.36% | -7.15% | 31.49% | -21.06% | 2025-10-29 | ||
| JNJ | JOHNSON & JOHNSON | $463.72B | $92.15B | $39.78B | $25.12B | $10.43 | 5.08% | 2.65% | 72.97% | 10.06% | |||
| GRFS | GRIFOLS SA | $6.57B | $8.01B | $1.71B | $174.36M | $0.26 | 2.57% | 5.57% | 258.21% | -25.16% | 2025-11-06 | ||
| AMRN | AMARIN CORP PLC | $402.49M | $219.36M | -$94.40M | -$103.59M | -$5.00 | -17.15% | -16.67% | N/A | N/A | |||
| AZN | ASTRAZENECA PLC | $258.54B | $56.50B | $18.51B | $8.30B | $2.68 | 15.00% | 17.07% | 28.61% | 26.68% | 2025-11-06 | ||
| LLY | ELI LILLY & CO | $777.08B | $53.26B | $18.75B | $13.80B | $15.35 | 36.83% | 18.34% | 88.34% | 19.92% | 2025-10-30 | ||
| SNY | SANOFI | $125.10B | $50.74B | $18.05B | $10.74B | $4.34 | 18.08% | 3.68% | 139.57% | -2.50% | 2025-10-24 | ||
| GILD | GILEAD SCIENCES INC | $149.82B | $28.86B | $10.97B | $6.31B | $5.05 | 3.81% | 5.41% | 494.12% | N/A | |||
| BMY | BRISTOL MYERS SQUIBB CO | $89.21B | $47.70B | $13.07B | $5.05B | $2.49 | 2.57% | 6.47% | N/A | N/A | 2025-10-30 | ||
| ABBV | ABBVIE INC | $403.22B | $58.33B | $13.80B | $3.76B | $2.11 | 6.05% | 9.99% | -29.67% | -14.87% | 2025-11-05 | ||
| AMGN | AMGEN INC | $157.68B | $34.92B | $15.89B | $6.62B | $12.32 | 12.88% | 7.52% | 110.60% | -0.02% | 2025-10-29 | ||
| SCLX | SCILEX HOLDING CO | $101.48M | $44.24M | -$68.46M | -$122.99M | -$10.73 | -12.98% | N/A | N/A | N/A | |||
| OGN | ORGANON & CO | $2.35B | $6.28B | $1.50B | $700.00M | $2.71 | -1.02% | N/A | -30.69% | N/A | 2025-10-30 | ||
| PFE | PFIZER INC | $140.26B | $63.83B | $17.31B | $10.75B | $1.89 | 13.54% | 13.12% | N/A | -5.52% | 2025-11-04 | ||
| MRK | MERCK & CO INC | $217.76B | $63.62B | $25.03B | $16.41B | $6.50 | 1.82% | 10.88% | 20.15% | 9.49% | 2025-10-30 | ||
| MIRA | MIRA PHARMACEUTICALS INC | $29.56M | $0.00 | -$7.84M | -$7.77M | -$0.49 | N/A | N/A | N/A | N/A | 2025-12-03 | ||
| MDCX | MEDICUS PHARMA LTD | $43.29M | $0.00 | -$16.73M | -$16.51M | -$1.34 | N/A | N/A | N/A | N/A | 2025-11-21 | ||
| NSRX | NASUS PHARMA LTD | N/A | $0.00 | -$1.50M | -$1.53M | -$0.22 | N/A | N/A | N/A | N/A |
General Drug Manufacturer Stocks FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.